Writing
Tagged “guidance”
2 pieces tagged “guidance”, across articles and the blog.
-
Clarity enables compliance. Ambiguity drives overcompliance.
FDA’s cybersecurity guidance for medical devices is strong on principle and fuzzy on threshold. That gap does not reduce burden. It moves the interpretation downstream, and companies overbuild to defend themselves.
-
The regulatory door just opened for new approach methodologies
FDA’s draft guidance on non-animal methods runs on two principles: context of use and weight of evidence. Together they tell you exactly where a predictive model is allowed to sit.